0.017291
0.000000
0.000000
0.000000
0.017291
0.000000
0.000000
0.000000
0.018234
0.00000
0.00000
0.00000
Brzozowski, A.M.
Jiracek, J.
Zakova, L.
Antolikova, E.
Watson, C.J.
Turkenburg, J.P.
Dodson, G.G.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
16
90.00
90.00
90.00
57.832
57.832
54.842
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
N
1
N
N
N
2
S
C
N
3
N
C
N
4
N
O
N
5
N
C
N
6
N
O
N
7
N
H
N
8
N
H
N
9
N
H
N
10
N
H
N
11
N
H
N
12
N
H
N
13
N
H
N
14
N
N
N
15
S
C
N
16
N
C
N
17
N
O
N
18
N
C
N
19
N
C
N
20
N
C
N
21
N
N
N
22
N
C
N
23
N
N
N
24
N
N
N
25
N
O
N
26
N
H
N
27
N
H
N
28
N
H
N
29
N
H
N
30
N
H
N
31
N
H
N
32
N
H
N
33
N
H
N
34
N
H
N
35
N
H
N
36
N
H
N
37
N
H
N
38
N
H
N
39
N
H
N
40
N
H
N
41
N
N
N
42
S
C
N
43
N
C
N
44
N
O
N
45
N
C
N
46
N
C
N
47
N
O
N
48
N
N
N
49
N
O
N
50
N
H
N
51
N
H
N
52
N
H
N
53
N
H
N
54
N
H
N
55
N
H
N
56
N
H
N
57
N
H
N
58
N
N
N
59
R
C
N
60
N
C
N
61
N
O
N
62
N
C
N
63
N
S
N
64
N
O
N
65
N
H
N
66
N
H
N
67
N
H
N
68
N
H
N
69
N
H
N
70
N
H
N
71
N
H
N
72
N
N
N
73
S
C
N
74
N
C
N
75
N
O
N
76
N
C
N
77
N
C
N
78
N
C
N
79
N
O
N
80
N
N
N
81
N
O
N
82
N
H
N
83
N
H
N
84
N
H
N
85
N
H
N
86
N
H
N
87
N
H
N
88
N
H
N
89
N
H
N
90
N
H
N
91
N
H
N
92
N
N
N
93
S
C
N
94
N
C
N
95
N
O
N
96
N
C
N
97
N
C
N
98
N
C
N
99
N
O
N
100
N
O
N
101
N
O
N
102
N
H
N
103
N
H
N
104
N
H
N
105
N
H
N
106
N
H
N
107
N
H
N
108
N
H
N
109
N
H
N
110
N
H
N
111
N
N
N
112
N
C
N
113
N
C
N
114
N
O
N
115
N
O
N
116
N
H
N
117
N
H
N
118
N
H
N
119
N
H
N
120
N
H
N
121
N
N
N
122
S
C
N
123
N
C
N
124
N
O
N
125
N
C
Y
126
N
C
Y
127
N
N
Y
128
N
C
Y
129
N
C
Y
130
N
N
N
131
N
O
N
132
N
H
N
133
N
H
N
134
N
H
N
135
N
H
N
136
N
H
N
137
N
H
N
138
N
H
N
139
N
H
N
140
N
H
N
141
N
H
N
142
N
O
N
143
N
H
N
144
N
H
N
145
N
N
N
146
S
C
N
147
N
C
N
148
N
O
N
149
S
C
N
150
N
C
N
151
N
C
N
152
N
C
N
153
N
O
N
154
N
H
N
155
N
H
N
156
N
H
N
157
N
H
N
158
N
H
N
159
N
H
N
160
N
H
N
161
N
H
N
162
N
H
N
163
N
H
N
164
N
H
N
165
N
H
N
166
N
H
N
167
N
N
N
168
S
C
N
169
N
C
N
170
N
O
N
171
N
C
N
172
N
C
N
173
N
C
N
174
N
C
N
175
N
O
N
176
N
H
N
177
N
H
N
178
N
H
N
179
N
H
N
180
N
H
N
181
N
H
N
182
N
H
N
183
N
H
N
184
N
H
N
185
N
H
N
186
N
H
N
187
N
H
N
188
N
H
N
189
N
N
N
190
S
C
N
191
N
C
N
192
N
O
N
193
N
C
Y
194
N
C
Y
195
N
C
Y
196
N
C
Y
197
N
C
Y
198
N
C
Y
199
N
C
N
200
N
O
N
201
N
H
N
202
N
H
N
203
N
H
N
204
N
H
N
205
N
H
N
206
N
H
N
207
N
H
N
208
N
H
N
209
N
H
N
210
N
H
N
211
N
H
N
212
N
N
N
213
S
C
N
214
N
C
N
215
N
O
N
216
N
C
N
217
N
C
N
218
N
C
N
219
N
O
N
220
N
H
N
221
N
H
N
222
N
H
N
223
N
H
N
224
N
H
N
225
N
H
N
226
N
H
N
227
N
H
N
228
N
H
N
229
N
N
N
230
S
C
N
231
N
C
N
232
N
O
N
233
N
C
N
234
N
O
N
235
N
O
N
236
N
H
N
237
N
H
N
238
N
H
N
239
N
H
N
240
N
H
N
241
N
H
N
242
N
H
N
243
N
N
N
244
S
C
N
245
N
C
N
246
N
O
N
247
R
C
N
248
N
O
N
249
N
C
N
250
N
O
N
251
N
H
N
252
N
H
N
253
N
H
N
254
N
H
N
255
N
H
N
256
N
H
N
257
N
H
N
258
N
H
N
259
N
H
N
260
N
N
N
261
S
C
N
262
N
C
N
263
N
O
N
264
N
C
Y
265
N
C
Y
266
N
C
Y
267
N
C
Y
268
N
C
Y
269
N
C
Y
270
N
C
N
271
N
O
N
272
N
O
N
273
N
H
N
274
N
H
N
275
N
H
N
276
N
H
N
277
N
H
N
278
N
H
N
279
N
H
N
280
N
H
N
281
N
H
N
282
N
H
N
283
N
H
N
284
N
N
N
285
S
C
N
286
N
C
N
287
N
O
N
288
N
C
N
289
N
C
N
290
N
C
N
291
N
O
N
292
N
H
N
293
N
H
N
294
N
H
N
295
N
H
N
296
N
H
N
297
N
H
N
298
N
H
N
299
N
H
N
300
N
H
N
301
N
H
N
302
N
H
N
1
N
sing
N
2
N
sing
N
3
N
sing
N
4
N
sing
N
5
N
sing
N
6
N
sing
N
7
N
doub
N
8
N
sing
N
9
N
sing
N
10
N
sing
N
11
N
sing
N
12
N
sing
N
13
N
sing
N
14
N
sing
N
15
N
sing
N
16
N
sing
N
17
N
sing
N
18
N
sing
N
19
N
doub
N
20
N
sing
N
21
N
sing
N
22
N
sing
N
23
N
sing
N
24
N
sing
N
25
N
sing
N
26
N
sing
N
27
N
sing
N
28
N
sing
N
29
N
sing
N
30
N
sing
N
31
N
sing
N
32
N
sing
N
33
N
doub
N
34
N
sing
N
35
N
sing
N
36
N
sing
N
37
N
sing
N
38
N
sing
N
39
N
sing
N
40
N
sing
N
41
N
sing
N
42
N
sing
N
43
N
sing
N
44
N
sing
N
45
N
doub
N
46
N
sing
N
47
N
sing
N
48
N
sing
N
49
N
sing
N
50
N
doub
N
51
N
sing
N
52
N
sing
N
53
N
sing
N
54
N
sing
N
55
N
sing
N
56
N
sing
N
57
N
sing
N
58
N
sing
N
59
N
sing
N
60
N
sing
N
61
N
doub
N
62
N
sing
N
63
N
sing
N
64
N
sing
N
65
N
sing
N
66
N
sing
N
67
N
sing
N
68
N
sing
N
69
N
sing
N
70
N
sing
N
71
N
sing
N
72
N
sing
N
73
N
sing
N
74
N
doub
N
75
N
sing
N
76
N
sing
N
77
N
sing
N
78
N
sing
N
79
N
sing
N
80
N
sing
N
81
N
sing
N
82
N
doub
N
83
N
sing
N
84
N
sing
N
85
N
sing
N
86
N
sing
N
87
N
sing
N
88
N
sing
N
89
N
sing
N
90
N
sing
N
91
N
sing
N
92
N
sing
N
93
N
doub
N
94
N
sing
N
95
N
sing
N
96
N
sing
N
97
N
sing
N
98
N
sing
N
99
N
sing
N
100
N
sing
N
101
N
doub
N
102
N
sing
N
103
N
sing
N
104
N
sing
N
105
N
sing
N
106
N
sing
N
107
N
sing
N
108
N
sing
N
109
N
sing
N
110
N
sing
N
111
N
doub
N
112
N
sing
N
113
N
sing
N
114
N
sing
N
115
N
sing
N
116
N
sing
N
117
N
sing
N
118
N
sing
N
119
N
sing
N
120
N
doub
N
121
N
sing
N
122
N
sing
N
123
N
sing
N
124
N
sing
Y
125
N
sing
Y
126
N
doub
Y
127
N
doub
N
128
N
sing
Y
129
N
sing
N
130
N
sing
Y
131
N
sing
N
132
N
sing
N
133
N
sing
N
134
N
sing
N
135
N
sing
N
136
N
sing
N
137
N
sing
N
138
N
sing
N
139
N
sing
N
140
N
sing
N
141
N
sing
N
142
N
sing
N
143
N
doub
N
144
N
sing
N
145
N
sing
N
146
N
sing
N
147
N
sing
N
148
N
sing
N
149
N
sing
N
150
N
sing
N
151
N
sing
N
152
N
sing
N
153
N
sing
N
154
N
sing
N
155
N
sing
N
156
N
sing
N
157
N
sing
N
158
N
sing
N
159
N
sing
N
160
N
sing
N
161
N
sing
N
162
N
sing
N
163
N
sing
N
164
N
doub
N
165
N
sing
N
166
N
sing
N
167
N
sing
N
168
N
sing
N
169
N
sing
N
170
N
sing
N
171
N
sing
N
172
N
sing
N
173
N
sing
N
174
N
sing
N
175
N
sing
N
176
N
sing
N
177
N
sing
N
178
N
sing
N
179
N
sing
N
180
N
sing
N
181
N
sing
N
182
N
sing
N
183
N
sing
N
184
N
sing
N
185
N
doub
N
186
N
sing
N
187
N
sing
N
188
N
sing
N
189
N
sing
Y
190
N
doub
Y
191
N
sing
Y
192
N
sing
N
193
N
sing
Y
194
N
doub
N
195
N
sing
Y
196
N
doub
N
197
N
sing
Y
198
N
sing
N
199
N
sing
N
200
N
sing
N
201
N
sing
N
202
N
sing
N
203
N
sing
N
204
N
sing
N
205
N
sing
N
206
N
sing
N
207
N
sing
N
208
N
doub
N
209
N
sing
N
210
N
sing
N
211
N
sing
N
212
N
sing
N
213
N
sing
N
214
N
sing
N
215
N
sing
N
216
N
sing
N
217
N
sing
N
218
N
sing
N
219
N
sing
N
220
N
sing
N
221
N
sing
N
222
N
sing
N
223
N
sing
N
224
N
sing
N
225
N
doub
N
226
N
sing
N
227
N
sing
N
228
N
sing
N
229
N
sing
N
230
N
sing
N
231
N
sing
N
232
N
sing
N
233
N
sing
N
234
N
sing
N
235
N
sing
N
236
N
sing
N
237
N
sing
N
238
N
doub
N
239
N
sing
N
240
N
sing
N
241
N
sing
N
242
N
sing
N
243
N
sing
N
244
N
sing
N
245
N
sing
N
246
N
sing
N
247
N
sing
N
248
N
sing
N
249
N
sing
N
250
N
sing
N
251
N
sing
N
252
N
sing
N
253
N
sing
N
254
N
doub
N
255
N
sing
N
256
N
sing
N
257
N
sing
N
258
N
sing
Y
259
N
doub
Y
260
N
sing
Y
261
N
sing
N
262
N
sing
Y
263
N
doub
N
264
N
sing
Y
265
N
doub
N
266
N
sing
Y
267
N
sing
N
268
N
sing
N
269
N
sing
N
270
N
sing
N
271
N
sing
N
272
N
sing
N
273
N
sing
N
274
N
sing
N
275
N
sing
N
276
N
sing
N
277
N
sing
N
278
N
doub
N
279
N
sing
N
280
N
sing
N
281
N
sing
N
282
N
sing
N
283
N
sing
N
284
N
sing
N
285
N
sing
N
286
N
sing
N
287
N
sing
N
288
N
sing
N
289
N
sing
US
Proc.Natl.Acad.Sci.USA
PNASA6
0040
0027-8424
107
1966
10.1073/PNAS.0911785107
20133841
Implications for the Active Form of Human Insulin Based on the Structural Convergence of Highly Active Hormone Analogues.
2010
10.2210/pdb2ws4/pdb
pdb_00002ws4
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
100
1
CCD
2009-02-20
ADSC CCD
SINGLE WAVELENGTH
M
x-ray
1
0.976
1.0
ID14-4
ESRF
0.976
SYNCHROTRON
ESRF BEAMLINE ID14-4
2383.698
INSULIN A CHAIN
1
syn
polymer
B27-B30 DELETION
2939.392
INSULIN B CHAIN
RESIDUES 25-50
YES
1
syn
polymer
18.015
water
24
nat
water
no
no
GIVEQCCTSICSLYQLENYCN
GIVEQCCTSICSLYQLENYCN
A
polypeptide(L)
no
no
FVNQHLCGSHLVEALYLVCGERGFFP
FVNQHLCGSHLVEALYLVCGERGFFP
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
1
2.3
47
NONE
3.0
0.055M NA2SO4 PH 3.0
chem_comp_atom
chem_comp_bond
database_2
pdbx_database_status
pdbx_initial_refinement_model
repository
Initial release
Database references
Derived calculations
Refinement description
Version format compliance
Data collection
Database references
Other
Refinement description
1
0
2010-02-09
1
1
2012-04-04
1
2
2023-12-20
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.status_code_sf
INSULIN (HUMAN) MUTANT WITH PHE B 24 REPLACED BY GLY (F24G) (NMR, REPRESENTATIVE PLUS 8 STRUCTURES)
NMR STRUCTURE OF HUMAN INSULIN MUTANT GLY- B8-SER, HIS-B10-ASP PRO-B28-LYS, LYS- B29-PRO, 20 STRUCTURES
INSULINE(1SEC) AND UV LASER EXCITED FLUORESCENCE
INSULIN (T3R3) (PH 6.4, 0.75 M NACL) COMPLEXED WITH TWO ZINC IONS AND TYLENOL ( 4'-HYDROXYACETANILIDE)
INSULINE(60SEC) AND UV LASER EXCITED FLUORESCENCE
NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12-ALA, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES
R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 10 STRUCTURES
CRYSTAL STRUCTURE OF DESTRIPEPTIDE (B28-B30) INSULIN
STRUCTURE OF INSULIN
T6 HUMAN INSULIN AT 1.0 A RESOLUTION
CRYSTALLOGRAPHIC AND SOLUTION STUDIES OF N- LITHOCHOLYL INSULIN: A NEW GENERATION OF PROLONGED-ACTING INSULINS.
FIRST PROTEIN STRUCTURE DETERMINED FROM X- RAY POWDERDIFFRACTION DATA
INSULIN (T3R3) (PH 5.6, 1.0 M NACL) COMPLEXED WITH TWO ZINC IONS AND TYLENOL ( 4'-HYDROXYACETANILIDE)
INSULIN MUTANT (B1, B10, B16, B27)GLU, DES -B30, NMR, 25 STRUCTURES
CRYSTAL STRUCTURE FORM ULTALENTE INSULIN MICROCRYSTALS
HUMAN INSULIN TWO DISULFIDE MODEL, NMR, 10 STRUCTURES
NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12-ABA, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES
NMR STRUCTURE OF THE HUMAN INSULIN-HIS(B16 )
DESPENTAPEPTIDE INSULIN IN ACETIC ACID (PH 2 )
HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR
MOL_ID: 1; MOLECULE: INSULIN; CHAIN: A, B; ENGINEERED: YES MUTATION: DES-[PHE(B 25)];
FIRST PROTEIN STRUCTURE DETERMINED FROM X- RAY POWDERDIFFRACTION DATA
MINI-PROINSULIN, TWO CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10)ASP, PRO(B 28)ASP, NMR, 20 STRUCTURES
HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH PHENOL
INSULIN MUTANT A3 GLY,(B1, B10, B16, B27) GLU, DES-B30, NMR, 19 STRUCTURES
CRYSTAL STRUCTURE FORM ULTALENTE INSULIN MICROCRYSTALS
INSULIN MUTANT A8 HIS,(B1, B10, B16, B27) GLU, DES-B30, NMR, 26 STRUCTURES
INSULIN (T3R3) COMPLEX WITH TWO ZINC IONS
THE STRUCTURE OF THE RESORCINOL/INSULIN R6 HEXAMER
STRUCTURE OF THE RHOMBOHEDRAL FORM OF THE M-CRESOL/INSULIN R6 HEXAMER
ENHANCING THE ACTIVITY OF INSULIN AT RECEPTOR EDGE: CRYSTALSTRUCTURE AND PHOTO- CROSS-LINKING OF A8 ANALOGUES
DEHYDRATED T6 HUMAN INSULIN AT 295 K
INSULIN AT PH 2: STRUCTURAL ANALYSIS OF THE CONDITIONS PROMOTING INSULIN FIBRE FORMATION.
R6 HUMAN INSULIN HEXAMER (NON-SYMMETRIC), NMR, 10 STRUCTURES
NMR STRUCTURE OF HUMAN INSULIN UNDER AMYLOIDOGENICCONDITION, 15 STRUCTURES
SOLUTION STRUCTURE OF THE MONOMERIC [THR(B27 )->PRO,PRO(B28)->THR] INSULIN MUTANT (PT INSULIN)
NON-STANDARD DESIGN OF UNSTABLE INSULIN ANALOGUES WITHENHANCED ACTIVITY
STRUCTURE OF B28 ASP INSULIN IN COMPLEX WITH PHENOL
DEHYDRATED T6 HUMAN INSULIN AT 100 K
HUMAN INSULIN DISULFIDE ISOMER, NMR, 10 STRUCTURES
SOLUTION STRUCTURE OF HUMAN PROINSULIN C- PEPTIDE
HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH RESORCINOL
1.3 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K
CRYSTAL STRUCTURE OF HUMAN INSULIN-DEGRADING ENZYME IN COMPLEX WITH INSULIN
R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 20 STRUCTURES
STRUCTURE OF THE MONOCLINIC FORM OF THE M -CRESOL/INSULIN R6 HEXAMER
CRYSTAL STRUCTURE OF ALLO-ILEA2-INSULIN, AN INACTIVE CHIRALANALOGUE: IMPLICATIONS FOR THE MECHANISM OF RECEPTOR
NMR STRUCTURE OF HUMAN INSULIN MUTANT GLY- B8-D-SER, HIS-B10-ASP PRO-B28-LYS, LYS -B29-PRO, 20 STRUCTURES
NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B5-ALA, HIS-B10-ASP PRO-B28-LYS, LYS- B29-PRO, 20 STRUCTURES
R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, ' GREEN' SUBSTATE, AVERAGE STRUCTURE
CRYSTAL STRUCTURE OF AN UNSTABLE INSULIN ANALOG WITH NATIVEACTIVITY.
NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-ALA, HIS-B10-ASP, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES
MOL_ID: 1; MOLECULE: INSULIN; CHAIN: A, B; ENGINEERED: YES MUTATION: S(B 9)D;
CRYSTAL STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH IODINATED INSULIN
NMR STRUCTURE OF HUMAN INSULIN IN 20% ACETIC ACID, ZINC-FREE, 10 STRUCTURES
NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-ALLO-ILE, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES
DIABETES-ASSOCIATED MUTATIONS IN HUMAN INSULIN : CRYSTALSTRUCTURE AND PHOTO-CROSS-LINKING STUDIES OF A-CHAINVARIANT INSULIN WAKAYAMA
R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, ' RED' SUBSTATE, AVERAGE STRUCTURE
1.2 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K
INSULIN, MONOCLINIC CRYSTAL FORM
STRUCTURE OF INSULIN
INSULIN (HUMAN, DES-PENTAPEPTIDE (B 26 - B 30)) (NMR, REPRESENTATIVE PLUS 14 STRUCTURES)
HUMAN INSULIN MUTANT SERB9GLU
R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, REFINED AVERAGE STRUCTURE
STRUCTURAL PROPERTIES OF THE B25TYR-NME- B26PHE INSULIN MUTANT.
INSULIN (HUMAN) MUTANT WITH PHE B 24 REPLACED BY SER (F24S) (NMR, REPRESENTATIVE PLUS 9 STRUCTURES)
LYS(B28)PRO(B29)-HUMAN INSULIN
AN ACTIVE MINI-PROINSULIN, M2PI
NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12-THR, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES
INSULIN MUTANT B16 GLU, B24 GLY, DES-B30 , NMR, 20 STRUCTURES
INSULIN COMPLEXED WITH 4-HYDROXYBENZAMIDE
NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-GLY, VAL-A3-GLY, HIS-B10-ASP, PRO- B28-LYS, LYS-B29-PRO, 20 STRUCTURES
SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN PROB26-DTI
SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMEALAB26-INSULIN AT PH 7.5
SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN PROB26-DTI IN MONOMER FORM
SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMETYRB26-INSULIN IN MONOMER FORM
SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMETYRB26-INSULIN IN HEXAMER FORM
SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMEALAB26-INSULIN AT PH 3.0
SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN D-PROB26-DTI-NH2
SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN NMEALAB26-DTI-NH2
SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN NMEHISB26-DTI-NH2
PDBE
Y
PDBE
2009-09-03
REL
REL
HOH
water
9606
HUMAN
HOMO SAPIENS
sample
9606
HUMAN
HOMO SAPIENS
sample
ENGINEERED RESIDUE IN CHAIN B, TYR 50 TO PRO
B27-B30 RESIDUES ARE DELETED
1MSO
PDB ENTRY 1MSO
PDB
experimental model
HOH
2001
3
HOH
HOH
2001
A
HOH
2002
3
HOH
HOH
2002
A
HOH
2003
3
HOH
HOH
2003
A
HOH
2004
3
HOH
HOH
2004
A
HOH
2005
3
HOH
HOH
2005
A
HOH
2006
3
HOH
HOH
2006
A
HOH
2007
3
HOH
HOH
2007
A
HOH
2008
3
HOH
HOH
2008
A
HOH
2009
3
HOH
HOH
2009
A
HOH
2010
3
HOH
HOH
2010
A
HOH
2011
3
HOH
HOH
2011
A
HOH
2012
3
HOH
HOH
2012
A
HOH
2013
3
HOH
HOH
2013
A
HOH
2001
3
HOH
HOH
2001
B
HOH
2002
3
HOH
HOH
2002
B
HOH
2003
3
HOH
HOH
2003
B
HOH
2004
3
HOH
HOH
2004
B
HOH
2005
3
HOH
HOH
2005
B
HOH
2006
3
HOH
HOH
2006
B
HOH
2007
3
HOH
HOH
2007
B
HOH
2008
3
HOH
HOH
2008
B
HOH
2009
3
HOH
HOH
2009
B
HOH
2010
3
HOH
HOH
2010
B
HOH
2011
3
HOH
HOH
2011
B
GLY
1
n
1
GLY
1
A
ILE
2
n
2
ILE
2
A
VAL
3
n
3
VAL
3
A
GLU
4
n
4
GLU
4
A
GLN
5
n
5
GLN
5
A
CYS
6
n
6
CYS
6
A
CYS
7
n
7
CYS
7
A
THR
8
n
8
THR
8
A
SER
9
n
9
SER
9
A
ILE
10
n
10
ILE
10
A
CYS
11
n
11
CYS
11
A
SER
12
n
12
SER
12
A
LEU
13
n
13
LEU
13
A
TYR
14
n
14
TYR
14
A
GLN
15
n
15
GLN
15
A
LEU
16
n
16
LEU
16
A
GLU
17
n
17
GLU
17
A
ASN
18
n
18
ASN
18
A
TYR
19
n
19
TYR
19
A
CYS
20
n
20
CYS
20
A
ASN
21
n
21
ASN
21
A
n
1
1
B
VAL
2
n
2
VAL
2
B
ASN
3
n
3
ASN
3
B
GLN
4
n
4
GLN
4
B
HIS
5
n
5
HIS
5
B
LEU
6
n
6
LEU
6
B
CYS
7
n
7
CYS
7
B
GLY
8
n
8
GLY
8
B
SER
9
n
9
SER
9
B
HIS
10
n
10
HIS
10
B
LEU
11
n
11
LEU
11
B
VAL
12
n
12
VAL
12
B
GLU
13
n
13
GLU
13
B
ALA
14
n
14
ALA
14
B
LEU
15
n
15
LEU
15
B
TYR
16
n
16
TYR
16
B
LEU
17
n
17
LEU
17
B
VAL
18
n
18
VAL
18
B
CYS
19
n
19
CYS
19
B
GLY
20
n
20
GLY
20
B
GLU
21
n
21
GLU
21
B
ARG
22
n
22
ARG
22
B
GLY
23
n
23
GLY
23
B
PHE
24
n
24
PHE
24
B
PHE
25
n
25
PHE
25
B
PRO
26
n
26
PRO
26
B
4.9835
-0.4820
1.6267
4.3855
0.0874
4.8392
-0.0491
-0.0063
0.1108
-0.1537
0.0741
0.0756
-0.1054
0.0775
-0.0249
0.0375
-0.0157
0.0121
0.0073
-0.0061
0.0136
refined
-10.3010
-8.4753
-10.8770
X-RAY DIFFRACTION
A
1
A
21
X-RAY DIFFRACTION
1
B
2
B
26
X-RAY DIFFRACTION
1
author_and_software_defined_assembly
PISA
4
tetrameric
3760
-41.2
5560
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
16_444
-y-1/2,-x-1/2,-z-1/2
crystal symmetry operation
-28.9160000000
-28.9160000000
-27.4210000000
1
A
CG
GLN
5
A
CG
GLN
5
0
Y
1
A
CD
GLN
5
A
CD
GLN
5
0
Y
1
A
OE1
GLN
5
A
OE1
GLN
5
0
Y
1
A
NE2
GLN
5
A
NE2
GLN
5
0
Y
1
B
CA
VAL
18
A
B
CA
VAL
18
0
Y
1
B
CB
VAL
18
A
B
CB
VAL
18
0
Y
1
B
CG1
VAL
18
A
B
CG1
VAL
18
0
Y
1
B
CG2
VAL
18
A
B
CG2
VAL
18
0
Y
1
B
CB
GLU
21
B
CB
GLU
21
0
Y
1
B
CG
GLU
21
B
CG
GLU
21
0
Y
1
B
CD
GLU
21
B
CD
GLU
21
0
Y
1
B
OE1
GLU
21
B
OE1
GLU
21
0
Y
1
B
OE2
GLU
21
B
OE2
GLU
21
0
Y
1
B
CG
ARG
22
B
CG
ARG
22
0
Y
1
B
CD
ARG
22
B
CD
ARG
22
0
Y
1
B
NE
ARG
22
B
NE
ARG
22
0
Y
1
B
CZ
ARG
22
B
CZ
ARG
22
0
Y
1
B
NH1
ARG
22
B
NH1
ARG
22
0
Y
1
B
NH2
ARG
22
B
NH2
ARG
22
0
Y
1
B
PHE
1
B
PHE
1
1
Y
1
A
A
CYS
ASN
20
21
136.75
1
21.60
2.20
113.40
135.00
A
A
A
CA
CB
CG
GLN
GLN
GLN
5
5
5
N
1
6.77
1.10
114.20
120.97
A
A
A
CA
CB
SG
CYS
CYS
CYS
20
20
20
N
1
A
A
CG
CD
GLU
GLU
4
4
0.110
0.015
1.515
1.625
N
1
A
A
CB
CG
GLN
GLN
5
5
-0.330
0.027
1.521
1.191
N
20.943
-2.02
0.00
0.00
-2.02
0.00
4.03
0.948
0.907
HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. U VALUES RESIDUAL. ONLY OCCUPANCY OF SIDE CHAINS A5,B18,B21,B22 ARE SET TO ZERO DUE TO THEIR HIGH MOBILITY. B1 IS NOT MODELLED AS IT IS FULLY DISORDERED
0.27816
0.22215
0.22448
1.90
20.00
170
3704
4.4
99.67
9.726
0.121
RANDOM
1
THROUGHOUT
MOLECULAR REPLACEMENT
0.432
0.170
0.80
0.80
1.40
PDB ENTRY 1MSO
MAXIMUM LIKELIHOOD
MASK
1.90
20.00
24
383
0
0
359
0.024
0.021
356
2.272
1.961
485
9.789
5.000
44
38.249
25.333
15
16.796
15.000
50
0.131
0.200
54
0.009
0.020
274
1.416
1.500
229
2.414
2.000
362
3.681
3.000
127
5.705
4.500
123
2.234
3.000
356
8.327
3.000
24
3.632
3.000
347
0.459
0.295
1.949
15
253
20
98.17
23.0
1.75
27.00
2WS4
4948
0.0
0.09
1
8.50
7.8
97.5
0.70
1.75
1.78
3.50
1
5.5
80.1
refinement
REFMAC
5.5.0082
data reduction
DENZO
data scaling
SCALEPACK
phasing
MOLREP
Semi-synthetic analogue of human insulin ProB26-DTI in monomer form
1
N
N
2
N
N
3
N
N
3
N
N
A
ILE
2
A
ILE
2
HELX_P
A
CYS
7
A
CYS
7
1
1
6
A
SER
12
A
SER
12
HELX_P
A
ASN
18
A
ASN
18
1
2
7
B
SER
9
B
SER
9
HELX_P
B
CYS
19
B
CYS
19
1
3
11
disulf
2.064
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
11
A
SG
CYS
11
1_555
disulf
2.053
A
CYS
7
A
SG
CYS
7
1_555
B
CYS
7
B
SG
CYS
7
1_555
disulf
1.999
A
CYS
20
A
SG
CYS
20
1_555
B
CYS
19
B
SG
CYS
19
1_555
HORMONE
INSULIN, CARBOHYDRATE METABOLISM, GLUCOSE METABOLISM, HORMONE, ANALOGUE, DIABETES MELLITUS
INS_HUMAN
UNP
1
P01308
INS_HUMAN
UNP
2
P01308
90
110
2WS4
1
21
P01308
A
1
1
21
25
50
2WS4
1
26
P01308
B
2
1
26
2
TYR
engineered mutation
PRO
26
2WS4
B
P01308
UNP
50
26
97
I 4 2 2